New Synthesis Method Produces Potential Treatment For Cocaine Addiction, Other Potent Biological Compounds

August 27, 1996



ORLANDO -- A breakthrough in basic chemistry achieved by University at Buffalo scientists has the potential to expand dramatically the variety and potency of new, pharmaceutical compounds. So far, the chemistry, which is based on the use of a chiral -- or "handed" -- catalyst, is being applied by the UB team to develop a variety of new chemical structures.

Among them is a compound to treat cocaine addiction that is undergoing toxicological studies at the National Institute of Drug Abuse at the National Institutes of Health.

Another compound developed by the UB team developed has demonstrated success in animal studies as an antidepressant. The method is based on a convergent synthesis strategy, an extremely efficient synthesis method where two large structural components are brought together to create a compound.

This approach makes it possible to control the synthesis of a wide range of biologically important compounds with specific chemical structures, that, until now, could not be synthesized efficiently in the laboratory. A patent on the method has been filed.

The chemistry and some of the compounds that have been synthesized using it were described here today (August 27, 1996) at the national meeting of the American Chemical Society

"We have developed a powerful, flexible method of synthesizing very important building blocks in organic synthesis," said Huw M.L. Davies, Ph.D., professor of chemistry at UB and lead investigator.

One of the most biologically active groups of compounds to which the new synthesis method is being applied are the tropanes, which show very high selectivity in their interaction with various regions of the brain. Efforts to develop a chemical treatment for addiction to cocaine, which is a tropane, have been hampered in the past by the lack of a reliable synthetic method.

#012#Existing methods have involved either starting with cocaine itself, which limited the structure of the final compound, or have involved many steps and resulted in very low yields. According to Davies, a major challenge in contemporary chemistry is the controlled synthesis of chiral molecules. He explained that such syntheses are important because chiral molecules and their mirror images are different structures and each can display different properties, especially when interacting with living organisms. Pharmaceutical companies therefore prefer to develop new chiral drugs as a single isomer so they can avoid concerns about the possible negative interactions of the inactive mirror-image structure. However, many existing methods of synthesizing tropanes and other biologically important chemicals produce an equal mixture of the two isomers. By using a small amount of a chiral metal catalyst, the UB scientists have found a way to predetermine that only one structure -- and not its mirror-image -- will be produced.

"We have designed a chiral catalyst that allows us to synthesize a structure with a high preference for one of two chiral compounds," said Davies. He stressed that these advantages make the new chemistry applicable to a diverse array of biologically important compounds.

"Because of its flexibility, this chemistry will allow not only our group, but many other synthetic organic research groups, to make some obvious compounds that no one has been able to make before," he noted.

In addition to compounds developed by the UB team, Nobel Laureate E.J. Corey of Harvard University has used the UB method to synthesize the active isomer of the antidepressant sertraline.

University at Buffalo

Related Cocaine Articles from Brightsurf:

Sleep-deprived mice find cocaine more rewarding
Sleep deprivation may pave the way to cocaine addiction. Too-little sleep can increase the rewarding properties of cocaine, according to new research in mice published in eNeuro.

Nucleus accumbens recruited by cocaine, sugar are different
In a study using genetically modified mice, a University of Wyoming faculty member found that the nucleus accumbens recruited by cocaine use are largely distinct from nucleus accumbens recruited by sucrose, or table sugar.

Astrocytes build synapses after cocaine use in mice
Drugs of abuse, like cocaine, are so addictive due in part to their cellular interaction, creating strong cellular memories in the brain that promote compulsive behaviors.

Of all professions, construction workers most likely to use opioids and cocaine
Construction workers are more likely to use drugs than workers in other professions, finds a study by the Center for Drug Use and HIV/HCV Research (CDUHR) at NYU College of Global Public Health.

Chronic cocaine use modifies gene expression
Chronic cocaine use changes gene expression in the hippocampus, according to research in mice recently published in JNeurosci.

Blocking dopamine weakens effects of cocaine
Blocking dopamine receptors in different regions of the amygdala reduces drug seeking and taking behavior with varying longevity, according to research in rats published in eNeuro.

Born to run: just not on cocaine
A study finds a surprising response to cocaine in a novel strain of mutant mice -- they failed to show hyperactivity seen in normal mice when given cocaine and didn't run around.

Cocaine adulterant may cause brain damage
People who regularly take cocaine cut with the animal anti-worming agent levamisole demonstrate impaired cognitive performance and a thinned prefrontal cortex.

Setting affects pleasure of heroin and cocaine
Drug users show substance-specific differences in the rewarding effects of heroin versus cocaine depending on where they use the drugs, according to a study published in JNeurosci.

One in 10 people have traces of cocaine or heroin on their fingerprints
Scientists have found that drugs are now so prevalent that 13 percent of those taking part in a test were found to have traces of class A drugs on their fingerprints -- despite never using them.

Read More: Cocaine News and Cocaine Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to